Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ABERG WISTEDT A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 32

  • Page / 2

Export

Selection :

  • and

COMPARISON BETWEEN ZIMELIDINE AND DESIPRAMINE IN ENDOGENOUS DEPRESSIONABERG WISTEDT A.1982; ACTA PSYCHIATR. SCAND.; ISSN 0001-690X; DNK; DA. 1982; VOL. 66; NO 2; PP. 129-138; BIBL. 19 REF.Article

A DOUBLE-BLIND STUDY OF ZIMELIDINE, A SEROTONIN UPTAKE INHIBITOR, AND DESIPRAMINE, A NORADRENALINE UPTAKE INHIBITOR, IN ENDOGENOUS DEPRESSIONABERG WISTEDT A.1982; ACTA PSYCHIATR. SCAND.; ISSN 0001-690X; DNK; DA. 1982; VOL. 66; NO 1; PP. 50-65; BIBL. 3 P.Article

INHIBITORS OF SEROTONIN AND NORADRENALINE UPTAKE IN HUMAN PLASMA AFTER WITH DRAWAL OF ZIMELIDINE AND CLOMIPRAMINE TREATMENTROSS SB; ABERG WISTEDT A.1983; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1983; VOL. 79; NO 4; PP. 298-303; BIBL. 29 REF.Article

The antidepressant effects of 5-HT uptake inhibitorsABERG-WISTEDT, A.British journal of psychiatry (Print). 1989, Vol 155, pp 32-40, issn 0007-1250, suppl. 8Conference Paper

A DOUBLE-BLIND STUDY OF ZIMELIDINE, A SEROTONIN UPTAKE INHIBITOR, AND DESIPRAMINE, A NORADRENALINE UPTAKE INHIBITOR, IN ENDOGENOUS DEPRESSIONABERG WISTEDT A; ROSS SB; JOSTELL KG et al.1982; ACTA PSYCHIATR. SCAND.; ISSN 0001-690X; DNK; DA. 1982; VOL. 66; NO 1; PP. 66-82; BIBL. 2 P.Article

EFFECTS OF ZIMELIDINE AND DESIPRAMINE ON SEROTONIN AND NORADRENALINE UPTAKE MECHANISMS IN RELATION TO PLASMA CONCENTRATIONS AND TO THERAPEUTIC EFFECTS DURING TREATMENT OF DEPRESSIONABERG WISTEDT A; JOSTELL KG; ROSS SB et al.1981; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1981; VOL. 74; NO 4; PP. 297-305; BIBL. 1 P.Article

Serotonin uptake inhibition during treatment of depression with nortriptyline caused by parent drug and not by 10-hydroxymetabolitesMALMGREN, R; ABERG-WISTEDT, A; BERTILSSON, L et al.Psychopharmacologia. 1987, Vol 92, Num 2, pp 169-172, issn 0033-3158Article

Increased platelet 5-HT2 receptor binding after electroconvulsive therapy in depressionSTAIN-MALMGREN, R; THAM, A; ABERG-WISTEDT, A et al.The Journal of ECT. 1998, Vol 14, Num 1, pp 15-24, issn 1095-0680Article

Aberrant seasonal variations of platelet serotonin uptake in endogenous depressionMALMGREN, R; ABERG-WISTEDT, A; MARTENSSON, B et al.Biological psychiatry (1969). 1989, Vol 25, Num 4, pp 393-402, issn 0006-3223Article

Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia : a randomized controlled trialMORTBERG, E; CLARK, D. M; SUNDIN, O et al.Acta psychiatrica Scandinavica. 2007, Vol 115, Num 2, pp 142-154, issn 0001-690X, 13 p.Article

Glucuronidation of amitriptyline in man in vivoDAHL-PUUSTINEN, M.-L; ABERG-WISTEDT, A; BERTILSSON, L et al.Pharmacology & toxicology. 1989, Vol 65, Num 1, pp 37-39, issn 0901-9928Article

Platelet serotonergic functions and light therapy in seasonal affective disorderSTAIN-MALMGREN, R; KJELLMAN, B. F; ABERG-WISTEDT, A et al.Psychiatry research. 1998, Vol 78, Num 3, pp 163-172, issn 0165-1781Article

Attempted suicide predicts suicide risk in mood disordersNORDSTRÖM, P; ASBERG, M; ABERG-WISTEDT, A et al.Acta psychiatrica Scandinavica. 1995, Vol 92, Num 5, pp 345-350, issn 0001-690XArticle

Rapid conjugation in an extremely rapid hydroxylator of debrisoquine: a case report supporting a coregulation of certain phase I and II metabolic reactionsBERTILSSON, L; ABERG-WISTEDT, A; DUMONT, E et al.Therapeutic drug monitoring. 1988, Vol 10, Num 2, pp 242-244, issn 0163-4356Article

Electroconvulsive therapy effects on cerebrospinal fluid monoamine metabolites and platelet serotonin uptake in melancholiaABERG-WISTEDT, A; MARTENSSON, B; BERTILSSON, L et al.Convulsive therapy. 1986, Vol 2, Num 2, pp 91-98, issn 0749-8055Article

Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressantsBERTILSSON, L; ABERG-WISTEDT, A; GUSTAFSSON, L. L et al.Therapeutic drug monitoring. 1985, Vol 7, Num 4, pp 478-480, issn 0163-4356Article

Fluoxetine inhibits the metabolism of tolterodine-pharmacokinetic implications and proposed clinical relevanceBRYNNE, N; SVANSTRÖM, C; ABERG-WISTEDT, A et al.British journal of clinical pharmacology. 1999, Vol 48, Num 4, pp 553-563, issn 0306-5251Article

Two-year outcome of team-based intensive case management for patients with schizophreniaABERG-WISTEDT, A; CRESSELL, T; LIDBERG, Y et al.Psychiatric services (Washington, D.C.). 1995, Vol 46, Num 12, pp 1263-1266, issn 1075-2730Article

Alprazolam does not inhibit the metabolism of nortriptyline in depressed patients or inhibit the metabolism of desipramine in human liver microsomesBERTILSSON, L; ABERG-WISTEDT, A; LIDEN, A et al.Therapeutic drug monitoring. 1988, Vol 10, Num 2, pp 231-233, issn 0163-4356Article

Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimeldineABERG-WISTEDT, A; ALVARIZA, M; BERTILSSON, L et al.Acta psychiatrica Scandinavica. 1985, Vol 71, Num 3, pp 256-268, issn 0001-690XArticle

Serotonergic function in major depression and effect of sertraline and paroxetine treatmentSTAIN-MALMGREN, R; EL KHOURY, A; ABERG-WISTEDT, A et al.International clinical psychopharmacology. 2001, Vol 16, Num 2, pp 93-101, issn 0268-1315Article

Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patientsBERTILSSON, L; OTANI, K; DAHL, M.-L et al.Pharmacology & toxicology. 1991, Vol 68, Num 2, pp 100-103, issn 0901-9928, 4 p.Article

Impaired neuropsychological performance in euthymic patients with recurring mood disordersTHAM, A; ENGELBREKTSON, K; MATHE, A. A et al.The Journal of clinical psychiatry. 1997, Vol 58, Num 1, pp 26-29, issn 0160-6689Article

Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorderWAGNER, A; ABERG-WISTEDT, A; ASBERG, M et al.Archives of general psychiatry. 1987, Vol 44, Num 10, pp 870-877, issn 0003-990XArticle

A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHDRYDEN, E; THASE, M. E; STRAHT, D et al.Acta psychiatrica scandinavica. 2009, Vol 120, Num 3, pp 239-246, issn 0001-690X, 8 p.Article

  • Page / 2